Related news and resources
Seventh meeting of the Subsidiary Body on Implementation (SBI-7): Digital sequence information on genetic resources
On 4 August 2026 in Nairobi, Kenya, IFPMA shared a statement at the seventh meeting of the Subsidiary Body on Implementation on digital sequence information on genetic resources. IFPMA welcomes the opportunity to address this agenda item. Our member companies support the objectives of the Convention and the Kunming-Montreal Global Biodiversity Framework. As Parties consider...
Read moreHealthy planet, healthy people: The innovative pharmaceutical industry’s contribution to the Kunming-Montreal Global Biodiversity Framework
Through company-level initiatives and decades of pre-competitive collaboration, IFPMA member companies are working to reduce environmental impact and contribute positively to a healthy and biodiverse planet.
Read more
Global biopharmaceutical CEOs response to reforms introduced in Germany
In response to reforms adopted by the German government on 10 July, BCR Secretary General, and IFPMA Director General, Dr. David Reddy, said: “The legislation passed by the German government undermines the value of medical innovation, global competitiveness and patient access to new medicines. Failing to reflect the value that medicines and vaccines bring, will negatively...
Read more